TNDM Q2 2023 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$196M-2.2% YoY

Gross Profit

$102M51.9% margin

Operating Income

-$39M-19.8% margin

Net Income

-$36M-18.3% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

+15.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$14M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$947M

Total Liabilities

$617M

Stockholders' Equity

$329M

Cash & Equivalents

$131M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$196M	$200M	-2.2%
Gross Profit	$102M	$102M	-0.2%
Operating Income	-$39M	-$12M	-217.1%
Net Income	-$36M	-$15M	-137.6%

Geographic Segments

UNITED STATES

$143M73%

Non-US

$53M27%